We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Letter from Minister Johnson to the Chair of the Advisory Council on the Misuse of Drugs (ACMD) setting out the priorities for ACMD's work programme.
Professor Owen Bowden-Jones, Chair, Advisory Council on the Misuse of…
A new study published by UKHSA shows some bacteria have already become resistant to one of the newest antibiotics introduced to the NHS.
Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2025.
ACMD Chair: Prof Owen Bowden-Jones ACMD Secretary: Zahi Sulaiman 1st Floor…
Government response to the ACMD's advice on increasing the level of tetrahydrocannabinol (THC) permissible in industrial hemp from 0.2-0.3% and assessment after 2 years.
Four more experts have been appointed members to the Advisory Council on the Misuse of Drugs.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine.
Changes to the Misuse of Drugs Act 1971 to control 22 substances, with 2-benzyl benzimidazole variants (nitazenes) falling under a new generic definition.
Ten leading experts have joined the Advisory Council on the Misuse of Drugs (ACMD) to strengthen its vital work advising the government on drug harms.
The government will seek expert advice on reclassifying ketamine to become a Class A substance.
The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.
The government will fund research into wearable technology, virtual reality and artificial intelligence in a bid to support people with drug addictions.
Legislation has been laid in Parliament to ban xylazine and 21 other dangerous drugs.
Confiscated and surrendered drugs will be tested to identify toxic substances in circulation and help prevent drug-related overdoses.
First published during the 2022 to 2024 Sunak Conservative government
The government responds to the ACMD's report on recently encountered novel benzodiazepines and related compounds.
Government response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237.
New 10-year plan to expand and improve the drug and alcohol workforce published.
The government will place 6 new synthetic opioids under the strictest level of control.
Minister for Crime, Policing and Fire promotes the UK’s balanced approach towards tackling drug use, with a focus on the challenge of synthetic opioids.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the fees applicable under the hemp licensing regime.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).